Melanoma Trial, Recruiting (NCT04068155)

Melanoma Trial, Recruiting NCT04068155 Sponsor: Alpha Tau Medical LTD. Condition: Melanoma

Printed from Voxsanity (voxsanity.com.au) — NCT04068155 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Melanoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a skin cancer that has been confirmed by a tissue test (biopsy), either newly diagnosed or returned after previous treatment, and it is one of these types: squamous cell carcinoma (SCC), basal cell carcinoma (BCC), lentigo maligna melanoma, or carcinosarcoma.
Your cancer is located on the skin (face, scalp, arms, legs, or torso), lips, or eyelids.
Your tumor measures 7 centimeters or smaller at its widest point.
Your tumor can be fully covered by the treatment seeds used in this trial (confirm with trial site).
Your disease can be measured using standard imaging methods known as RECIST v1.1 (confirm with trial site).
You are 18 years of age or older.
You are generally well enough to carry out basic daily activities without much difficulty (confirm with trial site).
Your doctors expect you to live for more than 6 months.
Your blood platelet count and blood clotting levels are within an acceptable range (confirm with trial site).
If you are a woman who could become pregnant, you have a negative pregnancy test result.
You are willing to sign a consent form agreeing to take part in the trial.

Who may not be able to join:

Your skin cancer is one of these types: keratoacanthoma, Merkel cell carcinoma, or a sarcoma other than carcinosarcoma.
Your cancer has spread to other parts of the body (metastatic disease).
You have other serious health conditions that your doctor believes could interfere with the trial results, such as poorly controlled autoimmune diseases or vasculitis.
You are currently taking medicines that suppress your immune system on an ongoing basis (short, occasional use of steroid medications may be acceptable — confirm with trial site).
You have taken part in another clinical trial involving a treatment in the past 30 days that could affect this trial's results.
Your doctor believes you are unlikely to be able to follow the trial's requirements.
You are not willing to sign the consent form.
You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dr Pascal POMMIER, Centre Leon Berard

Phone: +972-2-373-7000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04068155

Sponsor: Alpha Tau Medical LTD.

Phase: Not Applicable

Status: Recruiting

Condition: Melanoma

Trial contact: +972-2-373-7000

More information: https://clinicaltrials.gov/study/NCT04068155

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a skin cancer that has been confirmed by a tissue test (biopsy), either newly diagnosed or returned after previous treatment, and it is one of these types: squamous cell carcinoma (SCC), basal cell carcinoma (BCC), lentigo maligna melanoma, or carcinosarcoma.
Your cancer is located on the skin (face, scalp, arms, legs, or torso), lips, or eyelids.
Your tumor measures 7 centimeters or smaller at its widest point.
Your tumor can be fully covered by the treatment seeds used in this trial (confirm with trial site).
Your disease can be measured using standard imaging methods known as RECIST v1.1 (confirm with trial site).
You are 18 years of age or older.
You are generally well enough to carry out basic daily activities without much difficulty (confirm with trial site).
Your doctors expect you to live for more than 6 months.
Your blood platelet count and blood clotting levels are within an acceptable range (confirm with trial site).
If you are a woman who could become pregnant, you have a negative pregnancy test result.
You are willing to sign a consent form agreeing to take part in the trial.

Who may not be able to join:

Your skin cancer is one of these types: keratoacanthoma, Merkel cell carcinoma, or a sarcoma other than carcinosarcoma.
Your cancer has spread to other parts of the body (metastatic disease).
You have other serious health conditions that your doctor believes could interfere with the trial results, such as poorly controlled autoimmune diseases or vasculitis.
You are currently taking medicines that suppress your immune system on an ongoing basis (short, occasional use of steroid medications may be acceptable — confirm with trial site).
You have taken part in another clinical trial involving a treatment in the past 30 days that could affect this trial's results.
Your doctor believes you are unlikely to be able to follow the trial's requirements.
You are not willing to sign the consent form.
You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Alpha Tau Medical LTD.

Registry

ClinicalTrials.gov

Start date

1 April 2022

Est. completion

1 January 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

The objective response rate to DaRT treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov